MedPath

Registry of Cutting Balloon and DCB Intervention in Femoropopliteal Stenosis/Occlusion.

Conditions
Femoropoliteal Stenosis/Occlusion
Peripheral Artery Disease
Cutting-balloon
Drug-coated-balloon
Interventions
Device: Cutting-Balloon-PTA (VascuTrak) and Drug Coated Ballon PTA
Registration Number
NCT02198105
Lead Sponsor
Caritasklinik St. Theresia
Brief Summary

Observational registry including patients with peripheral artery disease due to femoro-popliteal stenosis or occlusion treated with cutting ballon- and subsequent drug-coated-ballon-percutaneous-transluminal-angioplasty (PTA).

Detailed Description

The registry includes consecutive patients with symptomatic peripheral artery disease due to femoro-popliteal stenosis or occlusion treated with cutting ballon- and subsequent drug-coated-ballon-percutaneous-transluminal-angioplasty (PTA).

Interventional procedure:

1. PTA with Cutting-Balloon (60-120 seconds).

2. PTA with Drug-Coated-Balloon (60 seconds).

Technical success is defined as

1. no recoil \>30%

2. no dissection \>Type B

3. no stenting \>30% of lesion length.

Follow-up of patients after 6 months and 12 months (ABI, Rutherford-classification, MACE, TLR, TVR, Binary Restenosis).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • peripheral artery disease (PAD) with femoro-popliteal stenosis >70% or occlusion (vessel diameter 4-6mm)
  • age 18-99
  • informed consent
Exclusion Criteria
  • proximal / iliacal stenosis
  • stenosis/occlusion of all arteries below the knee

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Femoropopliteal stenosisCutting-Balloon-PTA (VascuTrak) and Drug Coated Ballon PTAConsecutive patients with symptomatic peripheral artery disease due to femoro-popliteal stenosis/occlusion. Intervention with Cutting-Balloon-PTA (VascuTrak) and Drug Coated Ballon-PTA.
Primary Outcome Measures
NameTimeMethod
Clinically driven target lesion revascularization (TLR)6 months

clinically driven target lesion revascularization

Secondary Outcome Measures
NameTimeMethod
Binary restenosis12 months
clinically driven target vessel revascularization (TVR)12 months
Change in Ankle Brachial Index (ABI)12 months
Change in Rutherford-classification12 months
Amputation12 months
major cardiac adverse events12 months

myocardial infarction, stroke, death, cardiovascular death

Clinically driven target lesion revascularization (TLR)12 months

Trial Locations

Locations (1)

CaritasKlinikum, St. Theresia

🇩🇪

Saarbrücken, Saarland, Germany

© Copyright 2025. All Rights Reserved by MedPath